Natixis’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-732
Closed -$7.51K 1043
2025
Q1
$7.51K Buy
732
+667
+1,026% +$6.84K ﹤0.01% 874
2024
Q4
$787 Sell
65
-1,435
-96% -$17.4K ﹤0.01% 992
2024
Q3
$22K Buy
+1,500
New +$22K ﹤0.01% 809
2024
Q2
Sell
-19,573
Closed -$319K 1028
2024
Q1
$319K Sell
19,573
-439
-2% -$7.15K ﹤0.01% 653
2023
Q4
$298K Sell
20,012
-788,163
-98% -$11.7M ﹤0.01% 647
2023
Q3
$9.08M Buy
808,175
+585,700
+263% +$6.58M 0.07% 208
2023
Q2
$2.24M Buy
222,475
+115,850
+109% +$1.17M 0.02% 399
2023
Q1
$1M Sell
106,625
-1,196,691
-92% -$11.2M 0.01% 511
2022
Q4
$15.9M Buy
1,303,316
+835,291
+178% +$10.2M 0.09% 196
2022
Q3
$5.81M Sell
468,025
-737,096
-61% -$9.16M 0.03% 369
2022
Q2
$23.7M Sell
1,205,121
-457,603
-28% -$8.98M 0.09% 146
2022
Q1
$43.4M Buy
1,662,724
+210,802
+15% +$5.5M 0.15% 149
2021
Q4
$41.2M Buy
1,451,922
+794,591
+121% +$22.6M 0.14% 137
2021
Q3
$21M Buy
657,331
+641,793
+4,130% +$20.5M 0.07% 226
2021
Q2
$539K Sell
15,538
-857,102
-98% -$29.7M ﹤0.01% 703
2021
Q1
$25.7M Buy
872,640
+667,251
+325% +$19.7M 0.08% 223
2020
Q4
$6.3M Sell
205,389
-3,148,425
-94% -$96.6M 0.02% 475
2020
Q3
$93.7M Buy
3,353,814
+2,968,719
+771% +$82.9M 0.69% 35
2020
Q2
$8.26M Sell
385,095
-1,474,932
-79% -$31.6M 0.06% 217
2020
Q1
$41.6M Buy
1,860,027
+1,503,137
+421% +$33.7M 0.33% 73
2019
Q4
$10.5M Buy
+356,890
New +$10.5M 0.06% 274
2019
Q3
Sell
-412,552
Closed -$13.9M 836
2019
Q2
$13.9M Buy
+412,552
New +$13.9M 0.11% 176